Home›Compare›MangoRx vs MEDVi

MangoRx vs MEDVi: Which Is Better?

Head-to-head comparison of MangoRx and MEDVi based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

MEDVi scores higher overall in our independent evaluation (70.5/100 vs 58/100), leading on trust & safety, value, experience, reputation. MangoRx comes out ahead on product range. MangoRx has the lower entry price (from $50/mo vs $114/mo), so the better value depends on which treatment you need.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
71
MEDVi
Good

Direct-to-consumer telehealth platform selling compounded GLP-1 weight-loss medications and a compounded sublingual ED product, backed by a 40-year pharmacy partner.

Visit MEDVi

Score Breakdown

DimensionMangoRxMEDVi
Overall Score58/10070.5/100 ✓
Trust & Safety30%55/10073/100 ✓
Value25%62/10074/100 ✓
Experience20%58/10068/100 ✓
Product Range15%66/100 ✓65/100
Reputation10%45/10067/100 ✓

At a Glance

Founded20212023
HeadquartersDallas, TXNewark, DE
Publicly tradedYes (MGRX)No
Treatment categories53
Treatments listed55
Starting price$50/mo$114/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxMEDVi
Men's Health——
Sexual Health$59–$75
Mango ED (sildenafil or tadalafil)
$114
MEDVi QUAD (4-in-1 ED Sublingual)
Weight Loss / GLP-1$299
Slim (compounded oral semaglutide ODT)
$179–$299
Compounded Semaglutide (Injectable)

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

MEDVi

+Competitive GLP-1 intro pricing at $179/mo for semaglutide
+No long-term contract — month-to-month with no commitment required
+Established pharmacy partner (Belmar Pharma, 40+ years in operation)
−Significant price jump after month 1: semaglutide goes from $179 to $299 (67% increase)
−Difficult cancellation and refund process — 72-hour window, reports of 50+ contact attempts
−Trustpilot rating may be inflated by invited reviews; ConsumerAffairs paints much more negative picture
Read the full MEDVi review →

MangoRx vs MEDVi — FAQ

Is MangoRx better than MEDVi?

▾

MEDVi scores higher overall in our independent evaluation (70.5/100 vs 58/100), leading on trust & safety, value, experience, reputation. MangoRx comes out ahead on product range. MangoRx has the lower entry price (from $50/mo vs $114/mo), so the better value depends on which treatment you need.

Is MangoRx or MEDVi cheaper?

▾

MangoRx has the lower starting price (from $50/mo vs $114/mo for MEDVi). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and MEDVi both offer?

▾

Both platforms treat Men's Health, Sexual Health, Weight Loss / GLP-1. MangoRx covers 5 treatment categories total and MEDVi covers 3.

Still deciding?